Anders Björk
Impact in
- Immunology top 10%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Cancer therapeutics and mechanisms 2
- Angiogenesis and VEGF in Cancer 1
- S100 Proteins and Annexins 1
-
- Toxin Mechanisms and Immunotoxins 2
- Immunotherapy and Immune Responses 1
- Co-authors
- Tomas Leanderson (3 shared papers)Anders Olsson (3 shared papers)Fredrik Ivars (1 shared paper)Per Björk (1 shared paper)David Liberg (1 shared paper)Johannes Roth (1 shared paper)Thomas Vogl (1 shared paper)Martin Stenström (1 shared paper)
- Journals
- Organic Process Research & Development (1 paper)Molecular Cancer (1 paper)CNS Drug Reviews (1 paper)PLoS Biology (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Anders Björk
11 papers receiving 872 citations
Peers
Comparison fields: 5 of 86
- Immunology 247
- Biological Psychiatry 23
- Cancer Research 91
- Pulmonary and Respiratory Medicine 176
- Molecular Biology 400
Countries citing papers authored by Anders Björk
This map shows the geographic impact of Anders Björk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Björk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Björk more than expected).
Fields of papers citing papers by Anders Björk
This network shows the impact of papers produced by Anders Björk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Björk. The network helps show where Anders Björk may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Björk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 276 | |
| 2 | 2011 | 170 | |
| 3 | 2004 | 134 | |
| 4 | 2010 | 80 | |
| 5 | 2006 | 77 | |
| 6 | 1991 | 55 | |
| 7 | 1993 | 37 | |
| 8 | 1989 | 32 | |
| 9 | 2000 | 19 | |
| 10 | 2007 | 9 | |
| 11 | 1996 | 2 |
About Anders Björk
Anders Björk is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Cellular and Molecular Neuroscience and Small Animals, having authored 11 papers that have together received 891 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (2 papers), Cancer therapeutics and mechanisms (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Cyclopropane Reaction Mechanisms (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Meat and Animal Product Quality (1 paper), S100 Proteins and Annexins (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Immunology (247 citations), Biological Psychiatry (23 citations), Cancer Research (91 citations), Pulmonary and Respiratory Medicine (176 citations) and Molecular Biology (400 citations). Anders Björk has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Tomas Leanderson, Anders Olsson, Fredrik Ivars, Per Björk, David Liberg, Johannes Roth, Thomas Vogl, Martin Stenström, Роберто Пили and John T. Isaacs. Their work appears in journals such as Organic Process Research & Development, Molecular Cancer, CNS Drug Reviews, PLoS Biology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.